MAM
EGRX

Martingale Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Martingale Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,260
Closed -$433K – 889
2023
Q1 		$433K Buy
15,260
+400
+3% +$11.9K 0.01% 646
2022
Q4 		$434K Buy
14,860
+104
+0.7% +$3.31K 0.01% 645
2022
Q3 		$391K Buy
14,756
+651
+5% +$23.9K 0.01% 666
2022
Q2 		$627K Buy
14,105
+100
+0.7% +$4.59K 0.01% 599
2022
Q1 		$694K Buy
14,005
+150
+1% +$7.2K 0.01% 568
2021
Q4 		$707K Hold
13,855
– – 0.01% 568
2021
Q3 		$773K Buy
13,855
+8,150
+143% +$401K 0.01% 570
2021
Q2 		$245K Hold
5,705
– – ﹤0.01% 762
2021
Q1 		$240K Sell
5,705
-200
-3% -$9.29K ﹤0.01% 787
2020
Q4 		$276K Sell
5,905
-26,400
-82% -$1.23M ﹤0.01% 761
2020
Q3 		$1.37M Sell
32,305
-26,499
-45% -$1.16M 0.02% 534
2020
Q2 		$2.82M Buy
58,804
+3,100
+6% +$155K 0.03% 437
2020
Q1 		$2.56M Buy
55,704
+19,900
+56% +$999K 0.03% 436
2019
Q4 		$2.15M Buy
35,804
+31,304
+696% +$1.87M 0.02% 580
2019
Q3 		$256K Buy
+4,500
New +$253K ﹤0.01% 953

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Martingale Asset Management's EGRX Position: Q2 2023 in Review

Martingale Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 15,260 shares — an estimated $433K sold.

Martingale Asset Management first reported a position in EGRX in Q3 2019 and held it in 15 quarters. The position peaked at $2.82M in Q2 2020. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • Martingale Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Martingale Asset Management sold 15,260 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $433K.
  • Martingale Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2019 and held it in 15 quarters.
  • Martingale Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $2.82M in Q2 2020.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on Martingale Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.